Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Selvita S.A.
SLVCurrent price
54.8 PLN
-0.2 PLN (-0.36%)
Last closed
55.1 PLN
Company
selvita.com
ISIN
PLSLVCR00029
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
Warsaw Stock Exchange
Capitalization
1 020 147 801 PLN
Yield for 12 month
-9.27 %
1Y
3Y
5Y
10Y
15Y
SLV
Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, analytical and solid state chemistry, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, autoimmune/immunology, neurology, respiratory, and other. In addition, the company provides drug development services, including formulation development; CMC analytical support; stability and shelf-life determination; clinical supply/GMP manufacturing; small molecules bioanalysis; drug substance and product; and biologics and biosimilars bioanalysis services. Further, it offers research and development services in the areas of agrochemistry analytical support, and flavor and fragrance chemistry. Selvita S.A. was founded in 2007 and is headquartered in Kraków, Poland. Address: Hexagon, Kraków, Poland, 30-394
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
279.97 PLNP/E ratio
21.5891Dividend Yield
–Current Year
+346 192 249 PLN
Last Year
+359 885 000 PLN
Current Quarter
+79 935 420 PLN
Last Quarter
+76 171 733 PLN
Current Year
+275 191 093 PLN
Last Year
+291 970 027 PLN
Current Quarter
+61 373 424 PLN
Last Quarter
+58 838 023 PLN
Key Figures SLV
1 year
3 years
5 years
10 years
EBITDA
22 850 523 PLN
Operating Margin TTM
PE Ratio
21.5891
Return On Assets TTM
-0.13 %
PEG Ratio
–
Return On Equity TTM
16.19 %
Wall Street Target Price
279.97 PLN
Revenue TTM
328 296 796 PLN
Book Value
17.18 PLN
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-9.2 %
Dividend Yield
–
Gross Profit TTM
255 495 526 PLN
Earnings per share
2.57 PLN
Diluted Eps TTM
2.57 PLN
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
404 %
Profit Margin
14.41 %
Dividend Analytics SLV
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SLV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation SLV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
21.5891
Forward PE
–
Enterprise Value Revenue
3.8117
Price Sales TTM
3.1074
Enterprise Value EBITDA
11.968
Price Book MRQ
3.2348
Financials SLV
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SLV
For 52 weeks
50.29 PLN
72.84 PLN
50 Day MA
59.12 PLN
Shares Short Prior Month
–
200 Day MA
63.3 PLN
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart